ChEMBL ID: CHEMBL2109288
Mechanism of action: CD44 antigen binding agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to BIVATUZUMAB MERTANSINE